Brief: Herantis Pharma Partners With Indivi
19/05/2026 12:03
May 19 (Reuters) - Herantis Pharma Oyj HRTIS.HE: PARTNERS WITH INDIVI TO ENABLE DETECTION OF EARLY TREATMENT EFFECTS IN UPCOMING HER-096 PHASE 2 TRIAL IN PARKINSON'S DISEASE Source text: ID:nGNX5YSzpM Further company coverage: HRTIS.HE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))